Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001883850-22-000121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-13 | 2022-12-09 | REGN | VAGELOS P ROY | Dir | F - Tax | $753.28 | -57 | 322.4K | -0.0% | -$42.9K | |
| MI | 2022-12-13 | 2022-04-06+ | REGN | VAGELOS P ROY | Dir | G - Gift | $0.00 | -963 | 126.3K | -0.8% | $0 |
| 2022-12-13 | 2022-05-24 | REGN | VAGELOS P ROY | Dir | G - Gift | $0.00 | -23.1K | 322.5K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-09 | F | D | 57 | $753.28 | 322,432 | D by CLAT | — | — | |
| 2 | Common | Common Stock | 2022-04-06 | G | D | 302 | $0.00 | 126,704 | I by CLAT | — | — | |
| 3 | Common | Common Stock | 2022-10-03 | G | D | 304 | $0.00 | 126,043 | I | — | — | |
| 4 | Common | Common Stock | 2022-05-24 | G | D | 23,077 | $0.00 | 322,489 | D by CLAT | — | — | |
| 5 | Common | Common Stock | 2022-07-05 | G | D | 357 | $0.00 | 126,347 | I | — | — |